Amyloid deposition in the hippocampus and entorhinal cortex: Quantitative analysis of a transgenic mouse model
暂无分享,去创建一个
F. Bloom | J. Morrison | R. Rydel | D. Schenk | D. Games | S. Freedman | J. Reilly | John H Morrison | W. Young | John F Reilly | Warren G Young | Floyd E Bloom | Dora Games | Dale Schenk | Stephen Freedman | Russell E Rydel
[1] Brett Chromy,et al. Soluble oligomers of β amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus , 2002, Brain Research.
[2] L. Mucke,et al. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein , 1995, Nature.
[3] T. Freund,et al. Distribution, ultrastructure, and connectivity of calretinin‐immunoreactive mossy cells of the mouse dentate gyrus , 1997, Hippocampus.
[4] J. Morrison,et al. Stereologic assessment of the total cortical volume occupied by amyloid deposits and its relationship with cognitive status in aging and Alzheimer’s disease , 2002, Neuroscience.
[5] Koji Abe,et al. Amyloid cored plaques in Tg2576 transgenic mice are characterized by giant plaques, slightly activated microglia, and the lack of paired helical filament-typed, dystrophic neurites , 2002, Virchows Archiv.
[6] D. Price,et al. Disruption of Corticocortical Connections Ameliorates Amyloid Burden in Terminal Fields in a Transgenic Model of Aβ Amyloidosis , 2002, The Journal of Neuroscience.
[7] E. Perry,et al. Selective Nicotinic Receptor Consequences in APPSWE Transgenic Mice , 2002, Molecular and Cellular Neuroscience.
[8] C. Finch,et al. Targeting small Aβ oligomers: the solution to an Alzheimer's disease conundrum? , 2001, Trends in Neurosciences.
[9] G K Wilcock,et al. Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer disease. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[10] G. V. Van Hoesen,et al. Alzheimer's disease: cell-specific pathology isolates the hippocampal formation. , 1984, Science.
[11] R. Martins,et al. Altered glycosylation of acetylcholinesterase in APP (SW) Tg2576 transgenic mice occurs prior to amyloid plaque deposition , 2002, Journal of neurochemistry.
[12] J. Hardy,et al. The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .
[13] J. Morris,et al. Profound Loss of Layer II Entorhinal Cortex Neurons Occurs in Very Mild Alzheimer’s Disease , 1996, The Journal of Neuroscience.
[14] R. Armstrong. β-Amyloid Plaques: Stages in Life History or Independent Origin? , 1998, Dementia and Geriatric Cognitive Disorders.
[15] B. Sommer,et al. Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[16] D. Selkoe,et al. Normal and abnormal biology of the beta-amyloid precursor protein. , 1994, Annual review of neuroscience.
[17] D. Peterson,et al. Evidence That Synaptically Released β-Amyloid Accumulates as Extracellular Deposits in the Hippocampus of Transgenic Mice , 2002, The Journal of Neuroscience.
[18] B. Hyman,et al. Aβ Deposition Is Associated with Neuropil Changes, but not with Overt Neuronal Loss in the Human Amyloid Precursor Protein V717F (PDAPP) Transgenic Mouse , 1997, The Journal of Neuroscience.
[19] Gary Lynch,et al. Alterations in synaptic transmission and long-term potentiation in hippocampal slices from young and aged PDAPP mice , 1999, Brain Research.
[20] B. Ghetti,et al. A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease. , 1991, Science.
[21] J. Morrison,et al. Life and death of neurons in the aging brain. , 1997, Science.
[22] S. Hirai,et al. A variety of cerebral amyloid deposits in the brains of the Alzheimer-type dementia demonstrated byβ protein immunostaining , 2004, Acta Neuropathologica.
[23] S. Younkin,et al. Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice , 1996, Science.
[24] R. Nicoll,et al. Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[25] B T Hyman,et al. Growth Arrest of Individual Senile Plaques in a Model of Alzheimer's Disease Observed by In Vivo Multiphoton Microscopy , 2001, The Journal of Neuroscience.
[26] S. Paul,et al. Neuroanatomical Abnormalities in Behaviorally Characterized APPV717F Transgenic Mice , 2000, Neurobiology of Disease.
[27] S. Henriksen,et al. Age-independent and age-related deficits in visuospatial learning, sleep–wake states, thermoregulation and motor activity in PDAPP mice , 2002, Brain Research.
[28] D. Small,et al. Alzheimer's disease and Aβ toxicity: from top to bottom , 2001, Nature Reviews Neuroscience.
[29] J. Morrison,et al. Quantitative morphology and regional and laminar distributions of senile plaques in Alzheimer's disease , 1985, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[30] E. Masliah,et al. Genetically altered transgenic models of Alzheimer's disease. , 2000, Journal of neural transmission. Supplementum.
[31] P. Davies,et al. Dementia of the Alzheimer type. , 1980, Annual review of neuroscience.
[32] B. Sommer. Alzheimer's disease and the amyloid cascade hypothesis: ten years on. , 2002, Current opinion in pharmacology.
[33] B. Sommer,et al. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[34] R. Motter,et al. Amyloid precursor protein processing and A beta42 deposition in a transgenic mouse model of Alzheimer disease. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[35] H. Braak,et al. Sequence of Aβ‐Protein Deposition in the Human Medial Temporal Lobe , 2000 .
[36] W. Klein,et al. Selective neuronal degeneration induced by soluble oligomeric amyloid beta‐protein , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[37] K. Beyreuther,et al. A4 Protein in Alzheimer's Disease: Primary and Secondary Cellular Events in Extracellular Amyloid Deposition , 1989, Journal of neuropathology and experimental neurology.
[38] Yu-Min Kuo,et al. The Evolution of Aβ Peptide Burden in the APP23 Transgenic Mice: Implications for Aβ Deposition in Alzheimer Disease , 2001, Molecular medicine.
[39] Veerle Baekelandt,et al. Early Phenotypic Changes in Transgenic Mice That Overexpress Different Mutants of Amyloid Precursor Protein in Brain* , 1999, The Journal of Biological Chemistry.
[40] L. Mucke,et al. Comparison of Neurodegenerative Pathology in Transgenic Mice Overexpressing V717F β-Amyloid Precursor Protein and Alzheimer’s Disease , 1996, The Journal of Neuroscience.
[41] Yuan Su,et al. Selective deposition of amyloid‐β protein in the entorhinal‐dentate projection of a transgenic mouse model of alzheimer's disease , 1998, Journal of neuroscience research.
[42] Mikio Shoji,et al. Age-Dependent Changes in Brain, CSF, and Plasma Amyloid β Protein in the Tg2576 Transgenic Mouse Model of Alzheimer's Disease , 2001, The Journal of Neuroscience.
[43] B Urbanc,et al. Dynamics of plaque formation in Alzheimer's disease. , 1999, Biophysical journal.
[44] R. Palmiter,et al. ZnT-3, a putative transporter of zinc into synaptic vesicles. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[45] D. Price,et al. Mutant genes in familial Alzheimer's disease and transgenic models. , 1998, Annual review of neuroscience.
[46] R. Motter,et al. Amyloid precursor protein processing and Aβ42 deposition in a transgenic mouse model of Alzheimer disease , 1997 .
[47] S. Henriksen,et al. Loss of medial septal modulation of dentate gyrus physiology in young mice overexpressing human β-amyloid precursor protein , 2002, Neuroscience Letters.
[48] H. Braak,et al. Temporal Sequence of Alzheimer’s Disease-Related Pathology , 1999 .
[49] B. Hyman,et al. The Lack of Accumulation of Senile Plaques or Amyloid Burden in Alzheimer's Disease Suggests a Dynamic Balance Between Amyloid Deposition and Resolution , 1993, Journal of neuropathology and experimental neurology.
[50] H. Stanley,et al. Plaque‐Induced Abnormalities in Neurite Geometry in Transgenic Models of Alzheimer Disease: Implications for Neural System Disruption , 2001, Journal of neuropathology and experimental neurology.
[51] F. Tagliavini,et al. Preamyloid deposits in the cerebral cortex of patients with Alzheimer's disease and nondemented individuals , 1988, Neuroscience Letters.
[52] Russell E Jacobs,et al. Dentate gyrus volume is reduced before onset of plaque formation in PDAPP mice: A magnetic resonance microscopy and stereologic analysis , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[53] J. Vickers,et al. The morphological phenotype of β-amyloid plaques and associated neuritic changes in Alzheimer’s disease , 2001, Neuroscience.